SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Dec 19, 2007
Insider Transaction Report
Form 4
Lamm Robert
SVP, Quality & Reg. Affairs
Transactions
- Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-18$4.67/sh+5,000$23,350→ 47,418 total - Sale
Common Stock, $.01 par value per share
2007-12-18$20.10/sh−5,000$100,520→ 42,418 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-18$4.67/sh−5,000$23,350→ 5,000 totalExercise: $4.67From: 2003-06-10Exp: 2012-06-10→ Common Stock, $.01 par value per share (5,000 underlying)
Footnotes (1)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.